Committed to promoting biopharmaceutical innovation through artificial intelligence technology, providing intelligent solutions for human health
We are a biopharmaceutical technology company focused on AI-driven innovation, combining artificial intelligence, protein engineering, and drug discovery technologies to provide innovative R&D services for the pharmaceutical industry.
Suzhou Qizhiyuai Biotechnology Co., Ltd. is an innovative biotechnology company specializing in AI-driven protein expression and enzyme engineering optimization. Combining cutting-edge AI algorithms, synthetic biology platforms, and high-throughput experimental validation, we are committed to providing efficient and precise protein and enzyme optimization solutions for the pharmaceutical, industrial biology, green chemical, food, and environmental protection sectors.
Utilizing advanced AI technologies such as deep learning and machine learning to accelerate drug discovery and protein engineering processes, improving R&D efficiency and success rates.
Focusing on enzyme engineering and protein optimization, developing high-performance biocatalysts through rational design and directed evolution technologies.
Combining virtual screening, molecular docking, and other technologies to rapidly identify and optimize lead compounds, accelerating the new drug development process.